Research Office, Monash University, Clayton, VIC 3800, Australia.
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):231-5. doi: 10.1007/s11626-010-9278-2. Epub 2010 Feb 23.
Human embryonic stem (hES) cells were originally isolated and maintained on mouse embryonic fibroblast (MEF) feeder layers in the presence of fetal bovine serum (FBS). However, if the hES cells are to be used for therapeutic applications, it is preferable to regulatory authorities that they be derived and cultured in animal-free conditions to prevent mouse antigen contamination that would exacerbate an immune response to foreign proteins, and the potential risk of transmission of retroviral and other zoonotic pathogens to humans. As a step towards this goal, we derived a new hES cell line (MISCES-01) on human adult skin fibroblasts as feeder cells using serum replacement (SR) medium. The MISCES-01 cells have a normal diploid karyotype (46XX), express markers of pluripotency (OCT4, GCTM-2, TRA-1-60, TRA-1-81, SSEA-3, SSEA-4, and alkaline phosphatase) and following in vitro and in vivo differentiation, give rise to derivatives of the three primary germ layers. This cell line can be obtained for research purposes from the Australian Stem Cell Centre (http://www.stemcellcentre.edu.au).
人类胚胎干细胞(hES)最初是在含有胎牛血清(FBS)的情况下从小鼠胚胎成纤维细胞(MEF)饲养层上分离和维持的。然而,如果 hES 细胞将用于治疗应用,则监管机构更希望它们在无动物条件下衍生和培养,以防止小鼠抗原污染,从而加剧对外源蛋白的免疫反应,以及逆转录病毒和其他人畜共患病原体向人类传播的潜在风险。作为实现这一目标的一步,我们使用血清替代(SR)培养基从人成体皮肤成纤维细胞上衍生出一种新的 hES 细胞系(MISCES-01)作为饲养细胞。MISCES-01 细胞具有正常的二倍体核型(46XX),表达多能性标志物(OCT4、GCTM-2、TRA-1-60、TRA-1-81、SSEA-3、SSEA-4 和碱性磷酸酶),并在体外和体内分化后,产生三个原肠胚层的衍生物。该细胞系可从澳大利亚干细胞中心(http://www.stemcellcentre.edu.au)获得用于研究目的。